Gaucher and Pompe Diseases Enzyme Replacement Therapy Market, Global Outlook and Forecast 2023-2029

Report ID: MMG175021 | Category: Pharma & Healthcare | Pages: 67 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Enzyme replacement therapy (ERT) involves intravenous (IV) infusions to correct the underlying enzyme deficiency that causes symptoms of Gaucher disease
This report aims to provide a comprehensive presentation of the global market for Gaucher and Pompe Diseases Enzyme Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gaucher and Pompe Diseases Enzyme Replacement Therapy. This report contains market size and forecasts of Gaucher and Pompe Diseases Enzyme Replacement Therapy in global, including the following market information:
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gaucher and Pompe Diseases Enzyme Replacement Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gaucher and Pompe Diseases Enzyme Replacement Therapy include Pfizer Inc., Alexion Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., Ultragenyx Pharmaceutical Inc., Sigma-Tau Pharmaceuticals Inc., AbbVie Inc. and Sanofi SA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gaucher and Pompe Diseases Enzyme Replacement Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Segment Percentages, by Type, 2022 (%)
    Oral
    Parenteral
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Segment Percentages, by Application, 2022 (%)
    Hospital Pharmacies
    Retail Pharmacies
    Other
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gaucher and Pompe Diseases Enzyme Replacement Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gaucher and Pompe Diseases Enzyme Replacement Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Pfizer Inc.
    Alexion Pharmaceuticals Inc.
    BioMarin Pharmaceutical Inc.
    Ultragenyx Pharmaceutical Inc.
    Sigma-Tau Pharmaceuticals Inc.
    AbbVie Inc.
    Sanofi SA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gaucher and Pompe Diseases Enzyme Replacement Therapy, market overview.
Chapter 2: Global Gaucher and Pompe Diseases Enzyme Replacement Therapy market size in revenue.
Chapter 3: Detailed analysis of Gaucher and Pompe Diseases Enzyme Replacement Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gaucher and Pompe Diseases Enzyme Replacement Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Overall Market Size
    2.1 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size: 2022 VS 2029
    2.2 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Gaucher and Pompe Diseases Enzyme Replacement Therapy Players in Global Market
    3.2 Top Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Companies Ranked by Revenue
    3.3 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Gaucher and Pompe Diseases Enzyme Replacement Therapy Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Gaucher and Pompe Diseases Enzyme Replacement Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Gaucher and Pompe Diseases Enzyme Replacement Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Gaucher and Pompe Diseases Enzyme Replacement Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Gaucher and Pompe Diseases Enzyme Replacement Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size Markets, 2022 & 2029
        4.1.2 Oral
        4.1.3 Parenteral
    4.2 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue & Forecasts
        4.2.1 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2018-2023
        4.2.2 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2024-2029
        4.2.3 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2022 & 2029
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Other
    5.2 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue & Forecasts
        5.2.1 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2018-2023
        5.2.2 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2024-2029
        5.2.3 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2022 & 2029
    6.2 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue & Forecasts
        6.2.1 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2018-2023
        6.2.2 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2024-2029
        6.2.3 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2018-2029
        6.3.2 US Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.3.3 Canada Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.3.4 Mexico Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2018-2029
        6.4.2 Germany Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.4.3 France Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.4.4 U.K. Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.4.5 Italy Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.4.6 Russia Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.4.7 Nordic Countries Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.4.8 Benelux Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2018-2029
        6.5.2 China Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.5.3 Japan Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.5.4 South Korea Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.5.5 Southeast Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.5.6 India Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2018-2029
        6.6.2 Brazil Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.6.3 Argentina Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue, 2018-2029
        6.7.2 Turkey Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.7.3 Israel Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.7.4 Saudi Arabia Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
        6.7.5 UAE Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, 2018-2029
7 Gaucher and Pompe Diseases Enzyme Replacement Therapy Companies Profiles
    7.1 Pfizer Inc.
        7.1.1 Pfizer Inc. Company Summary
        7.1.2 Pfizer Inc. Business Overview
        7.1.3 Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Major Product Offerings
        7.1.4 Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue in Global Market (2018-2023)
        7.1.5 Pfizer Inc. Key News & Latest Developments
    7.2 Alexion Pharmaceuticals Inc.
        7.2.1 Alexion Pharmaceuticals Inc. Company Summary
        7.2.2 Alexion Pharmaceuticals Inc. Business Overview
        7.2.3 Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Major Product Offerings
        7.2.4 Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue in Global Market (2018-2023)
        7.2.5 Alexion Pharmaceuticals Inc. Key News & Latest Developments
    7.3 BioMarin Pharmaceutical Inc.
        7.3.1 BioMarin Pharmaceutical Inc. Company Summary
        7.3.2 BioMarin Pharmaceutical Inc. Business Overview
        7.3.3 BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Major Product Offerings
        7.3.4 BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue in Global Market (2018-2023)
        7.3.5 BioMarin Pharmaceutical Inc. Key News & Latest Developments
    7.4 Ultragenyx Pharmaceutical Inc.
        7.4.1 Ultragenyx Pharmaceutical Inc. Company Summary
        7.4.2 Ultragenyx Pharmaceutical Inc. Business Overview
        7.4.3 Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Major Product Offerings
        7.4.4 Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue in Global Market (2018-2023)
        7.4.5 Ultragenyx Pharmaceutical Inc. Key News & Latest Developments
    7.5 Sigma-Tau Pharmaceuticals Inc.
        7.5.1 Sigma-Tau Pharmaceuticals Inc. Company Summary
        7.5.2 Sigma-Tau Pharmaceuticals Inc. Business Overview
        7.5.3 Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Major Product Offerings
        7.5.4 Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue in Global Market (2018-2023)
        7.5.5 Sigma-Tau Pharmaceuticals Inc. Key News & Latest Developments
    7.6 AbbVie Inc.
        7.6.1 AbbVie Inc. Company Summary
        7.6.2 AbbVie Inc. Business Overview
        7.6.3 AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Major Product Offerings
        7.6.4 AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue in Global Market (2018-2023)
        7.6.5 AbbVie Inc. Key News & Latest Developments
    7.7 Sanofi SA
        7.7.1 Sanofi SA Company Summary
        7.7.2 Sanofi SA Business Overview
        7.7.3 Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy Major Product Offerings
        7.7.4 Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy Revenue in Global Market (2018-2023)
        7.7.5 Sanofi SA Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Gaucher and Pompe Diseases Enzyme Replacement Therapy Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?